{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:00:35Z","timestamp":1747166435201,"version":"3.40.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jtauto.2023.100227","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T04:03:55Z","timestamp":1702353835000},"page":"100227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of traditional therapeutics on prevalence and clinical outcomes of coronavirus disease 2019 in Chinese patients with autoimmune diseases"],"prefix":"10.1016","volume":"8","author":[{"given":"Saisai","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengru","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9338-2591","authenticated-orcid":false,"given":"Jun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2023.100227_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biochi.2020.09.018","article-title":"The emergence of COVID-19 as a global pandemic: understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2","volume":"179","author":"Muralidar","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.jtauto.2023.100227_bib2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-Infected pneumonia in wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jtauto.2023.100227_bib3","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(20)30673-5","article-title":"COVID-19: towards controlling of a pandemic","volume":"395","author":"Bedford","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jtauto.2023.100227_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cei.13239","article-title":"Pathogen infection and autoimmune disease","volume":"195","author":"Christen","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2023.100227_bib5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/annrheumdis-2019-216653","article-title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"79","author":"Sepriano","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2023.100227_bib6","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/ard.2011.151043","article-title":"Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?","volume":"70","author":"Strangfeld","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2023.100227_bib7","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3389\/fimmu.2020.01844","article-title":"Immunomodulatory drugs in the management of SARS-CoV-2","volume":"11","author":"Burrage","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2023.100227_bib8","first-page":"1023","article-title":"COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?","volume":"14","author":"Russell","year":"2020","journal-title":"Ecancer Med. Sci."},{"key":"10.1016\/j.jtauto.2023.100227_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1473-3099(20)30227-9","article-title":"Estimation of COVID-19 outbreak size in Italy","volume":"20","author":"Tuite","year":"2020","journal-title":"Lancet. Inf. Disp."},{"key":"10.1016\/j.jtauto.2023.100227_bib10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/annrheumdis-2020-218946","article-title":"Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis","volume":"80","author":"Akiyama","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2023.100227_bib11","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/art.41456","article-title":"COVID-19 in patients with inflammatory arthritis: a prospective study on the effects of comorbidities and disease-modifying antirheumatic drugs on clinical outcomes","volume":"72","author":"Haberman","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2023.100227_bib12","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S2213-2600(20)30415-X","article-title":"Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform","volume":"8","author":"Schultze","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jtauto.2023.100227_bib13","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.05.066","article-title":"Baseline disease activity and steroid therapy stratify risk of COVID-19 in patients with Inflammatory Bowel Disease","volume":"159","author":"Lukin","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtauto.2023.100227_bib14","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.1016\/S2665-9913(21)00151-X","article-title":"Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study","volume":"3","author":"Shin","year":"2021","journal-title":"Lancet. Rheumatol."},{"key":"10.1016\/j.jtauto.2023.100227_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102912","article-title":"Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov 2 Spike in patients with immune system diseases","volume":"133","author":"Renaudineau","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtauto.2023.100227_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100086","article-title":"Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: single center cohort study of 685 patients","volume":"4","author":"Luis","year":"2021","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.jtauto.2023.100227_bib17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2023.100227_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.202003-0821OC","article-title":"COVID-19-related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids","volume":"202","author":"Peters","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jtauto.2023.100227_bib19","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: a Meta-analysis","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jtauto.2023.100227_bib20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2023.100227_bib21","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1096\/fj.202000919","article-title":"Rethinking the role of hydroxychloroquine in the treatment of COVID-19","volume":"34","author":"Meyerowitz","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.jtauto.2023.100227_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jtauto.2023.100227_bib23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jtauto.2023.100227_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jtauto.2023.100227_bib25","doi-asserted-by":"crossref","unstructured":"Ozuygur Ermis SS, Ergan B, Kacmaz Basoglu O et al, The Efficacy of hydroxychloroquine and azithromycin combination therapy on hospital mortality in COVID 19 pneumonia patients, Turk. J. Med. Sci. https:\/\/doi:10.3906\/sag-2009-64.","DOI":"10.3906\/sag-2009-64"},{"key":"10.1016\/j.jtauto.2023.100227_bib26","first-page":"114","article-title":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19","volume":"1","author":"Magagnoli","year":"2020","journal-title":"M\u00e9d."},{"key":"10.1016\/j.jtauto.2023.100227_bib27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5114\/reum.2022.119039","article-title":"Influence of biologic and conventional disease-modifying antirheumatic drugs on COVID-19 incidence among rheumatic patients during the first and second wave of the pandemic in Iran","volume":"60","author":"Sahebari","year":"2022","journal-title":"Reumatologia"},{"key":"10.1016\/j.jtauto.2023.100227_bib28","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s11739-020-02535-5","article-title":"Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs","volume":"16","author":"Moradi","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.jtauto.2023.100227_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.55563\/clinexprheumatol\/r3k9l6","article-title":"COVID-19: the new challenge for rheumatologists","volume":"38","author":"Ferro","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2023.100227_bib30","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s10067-020-05073-9","article-title":"Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets","volume":"39","author":"Misra","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jtauto.2023.100227_bib31","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"95","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jtauto.2023.100227_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909023000400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909023000400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T21:43:37Z","timestamp":1718574217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909023000400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"alternative-id":["S2589909023000400"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2023.100227","relation":{},"ISSN":["2589-9090"],"issn-type":[{"type":"print","value":"2589-9090"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of traditional therapeutics on prevalence and clinical outcomes of coronavirus disease 2019 in Chinese patients with autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2023.100227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100227"}}